General and abdominal obesity trajectories across adulthood, and risk of prostate cancer: results from the PROtEuS study, Montreal, Canada
- 5 April 2021
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 32 (6) , 653-665
Abstract
Purpose Greater body fatness is a probable cause of advanced prostate cancer (PCa). Body fat distribution and timing of exposure may be relevant. We investigated associations between body size trajectories and PCa incidence in a population-based case–control study in Montreal, Canada. Methods Cases (n = 1,931), aged ≤ 75 years, were diagnosed with PCa in 2005–2009; 1,994 controls were selected from the electoral list. Interviews were conducted to assess body mass index (BMI) and Stunkard’s silhouette at ages 20, 40, 50, 60 years, and before interview. Current waist and hip circumferences were measured, and a predictive model estimated waist circumference in the past. BMI and waist circumference trajectories were determined to identify subgroups. Logistic regression estimated odds ratios (OR) and 95% confidence intervals (CI) for the association between anthropometric indicators and PCa. Results Subjects with a current BMI ≥ 30 kg/m2 had a lower risk of overall PCa (OR 0.71, 95% CI 0.59–0.85). Associations with adult BMI followed similar trends for less and more aggressive tumors, with stronger inverse relationships in early adulthood. Contrastingly, current waist circumference ≥ 102 cm was associated with elevated risk of high-grade PCa (OR 1.33, 95% CI 1.03–1.71). Men with increasing BMI or waist circumference adult trajectories had a lower risk of PCa, especially low-grade, than those in the normal-stable range. This was especially evident among men in the obese-increase group for BMI and waist circumference. Conclusion Abdominal obesity increased the risk of aggressive PCa. The inverse relationship between body size trajectories and PCa may reflect PSA hemodilution, lower detection, and/or a true etiological effect.Keywords
Funding Information
- Canadian Cancer Society (13149, 19500, 19864, 19865, 705562)
- Cancer Research Society
- Santé
- Ministère du Développement Économique, de l’Innovation et de l’Exportation
- Canadian Institutes of Health Research (CCP-155423)
- Fonds de Recherche du Québec - Santé (CA) RRSE
This publication has 59 references indexed in Scilit:
- The Use of Stunkard’s Figure Rating Scale to Identify Underweight and Overweight in Chinese AdolescentsPLOS ONE, 2012
- A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass IndexPLOS ONE, 2012
- Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective studyBritish Journal of Cancer, 2011
- Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall studyCancer Causes & Control, 2010
- Getting heavier, younger: trajectories of obesity over the life courseInternational Journal of Obesity, 2009
- Prostate Cancer Specific Mortality and Gleason 7 Disease Differences in Prostate Cancer Outcomes Between Cases With Gleason 4 + 3 and Gleason 3 + 4 Tumors in a Population Based CohortJournal of Urology, 2009
- A prospective Swedish study on body size, body composition, diabetes, and prostate cancer riskBritish Journal of Cancer, 2009
- Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysisInternational Journal of Cancer, 2009
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004